Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sucampo Pharma Americas, LLC
With
Takeda
Age
6–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has completed the 3-month placebo-controlled study (NCT02042183)
Will continue to abstain from taking concomitant medication (prescribed or over-the-counter) that affects gastrointestinal motility
You may not be if
Has untreated faecal impaction at the time of rolling over into study
Has significant change in medical status, newly diagnosed and uncontrolled cardiovascular, liver or lung disease, neurologic or psychiatric disorder, or other systemic disease
Has demonstrated non-compliance with study protocol during the 3-month placebo-controlled study (NCT02042183)
